Qingxia Zhao

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · BMJ · 2020 · 1.1K citations · Full text

Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · 2020 · 197 citations · Full text

Pharmacotherapy, Hcq Recipients, Covid-19 +19

Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention

Li Sun, Youmei Peng, Wenquan Yu et al. · Journal of Medicinal Chemistry · 2020 · 71 citations

Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy

Zheng Zhang, Junliang Fu, Qingxia Zhao et al. · The Journal of Immunology · 2006 · 61 citations · Full text

Primary Immunodeficiency, Pdc Subsets, Differential Restoration +15

Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation

Yan-Heng Zhou, Li Sun, Jun Chen et al. · mBio · 2019 · 49 citations · Full text